FAS and soft tissue sarcoma: The value of FAS in predicting GC prognosis is not yet confirmed, although FAS has been considered to be correlated with the prognosis of various tumors, such as non-small cell lung carcinoma (37), melanoma (38) and soft-tissue sarcomas (64).